Filing Details
- Accession Number:
- 0001179110-16-024927
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-17 19:02:55
- Reporting Period:
- 2016-05-13
- Filing Date:
- 2016-05-17
- Accepted Time:
- 2016-05-17 19:02:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1399519 | M David Weber | C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par Value | Disposition | 2016-05-13 | 628 | $94.27 | 116,783 | No | 4 | F | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2016-05-14 | 6,816 | $94.08 | 109,967 | No | 4 | F | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2016-05-16 | 4,000 | $94.42 | 105,967 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2016-05-16 | 1,604 | $94.91 | 104,363 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $5.86 | 2010-05-28 | 2019-05-28 | 0 | 33,000 | Direct |
| Common Stock | Stock Options (right to buy) | $5.86 | 2010-03-31 | 2019-05-28 | 0 | 34,500 | Direct |
| Common Stock | Stock Option (right to buy) | $10.03 | 2011-06-03 | 2020-06-03 | 0 | 50,000 | Direct |
| Common Stock | Stock Option (right to buy) | $22.44 | 2013-05-22 | 2022-05-22 | 0 | 25,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $23.15 | 2014-05-14 | 2023-05-14 | 0 | 23,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $21.55 | 2015-05-14 | 2024-05-14 | 0 | 15,000 | Direct |
| Common Stock | Stock Option (right to buy) | $66.25 | 2016-05-13 | 2025-05-13 | 0 | 10,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2019-05-28 | 0 | 33,000 | Direct |
| 2019-05-28 | 0 | 34,500 | Direct |
| 2020-06-03 | 0 | 50,000 | Direct |
| 2022-05-22 | 0 | 25,000 | Direct |
| 2023-05-14 | 0 | 23,000 | Direct |
| 2024-05-14 | 0 | 15,000 | Direct |
| 2025-05-13 | 0 | 10,000 | Direct |
Footnotes
- This option becomes exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- Transaction represents shares of common stock withheld solely for payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $93.8200 and $94.7900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $94.8400 and $95.0000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Billionaire Hedge Funds
